Published January 1, 2016
| Version v1
Journal article
Open
A quantitative adaptation of the Wayne test for pyrazinamide resistance
Creators
- 1. Asociac Benef PRISMA, San Miguel, Peru
- 2. Univ Peruana Cayetano Heredia, Lima, Peru
- 3. Univ Peruana Cayetano Heredia, Fac Sci, Res & Dev Labs, Lab TB Infect Dis, Lima, Peru
Description
Background: Pyrazinamide (PZA) is the most important drug against the latent stage of tuberculosis (TB) and is used in both first and second line treatment regimens. The continued increase in multi-drug resistant TB and the prevalence of PZA resistance makes the development of alternative assays for prompt identification of PZA resistance all the more important.
Files
bib-815d4f44-42dc-4f08-9ca9-97464e642837.txt
Files
(197 Bytes)
| Name | Size | Download all |
|---|---|---|
|
md5:635f1fbb5c2d7ea92bae94b8e1f2745f
|
197 Bytes | Preview Download |